跳至主要内容
临床试验/ACTRN12607000130460
ACTRN12607000130460已完成2 期

A pilot study to investigate the efficacy and tolerability of a combination of fenugreek/phaseolamin as a potential weight loss agent when given as part of a muesli bar in moderately obese patients

Southern European Health Marketing Ltd0 个研究点目标入组 39 人开始时间: 2007年2月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
25 Years 至 60 Years(—)
性别
All

入选标准

  • Overweight as defined by body mass index 30-40kg/m2Generally healthyWeight stable over previous 3 monthsWilling and able to give written informed consent.

排除标准

  • Diabetic (receiving pharmacological treatments for diabetes)Pregnant, breastfeeding, or intending to become pregnant during the studyAny medications, or medical conditions that might, in the opinion of the Principal Investigator, affect participant safety or outcomeCurrently on an alternative weight loss programme or planning to start a programme during the study durationHas a pace-makerPlanning international travel during the study.

研究者

发起方
Southern European Health Marketing Ltd

相似试验

Study of a combination of fenugreek/phaseolamin as a... | 临床试验